The Royal Wolverhampton NHS Trust

Specialist MDT: University Hospitals of North Midlands NHS Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services (updated 2022):

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Specialist continence services
    • Psychological counselling

Data Quality

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 214 1149
Performance Status recorded 22% 79%
PSA completed 75% 48%
Gleason Score completed 74% 79%
TNM completed 68% 84%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 1118 31258
Percentage of men diagnosed with metastatic disease 20% 19%

Management

Specialist MDT National
No. of men diagnosed with low-risk localised disease 145 3680
Percentage of men with low-risk localised disease receiving radical treatment 11% 9%
No. of men diagnosed with locally advanced disease 409 11503
Percentage of men diagnosed with locally advanced disease receiving radical treatment 66% 69%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (Apr 2021 - Mar 2022) 95
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 18%
No. of men who received radical prostatectomy (Sep 2019 - August 2020) 121
Adjusted percentage of men experiencing at least one GU complication (%) 1%
No. of men who received radical radiotherapy (Sep 2019 - August 2020) 212
Adjusted percentage of men experiencing at least one GI complication (%) 8%

Compare provider outcomes